Converge Bio’s $25M Series A Is a Vote for “GenAI Labs” in Drug Discovery (and a Warning About Hallucinating Molecules)
On January 13, 2026, TechCrunch reported that Converge Bio, an AI drug-discovery startup with operations spanning Boston and Tel Aviv, raised $25 million in a Series A round. The round…